JCI
US$ 25.07
how to track glp-1 diet trends for cpg product development Consumer | Retail Strategy Impact of GLP-1 Drug Adoption
Description
Renal: acute renal failure or worsening of chronic renal failure, sometimes requiring hemodialysis Skin and Subcutaneous Tissue: alopecia
Thrush in men and women
GLP-1 receptor agonists obesity drugs market is expected to grow at a noteworthy CAGR, driven by the National Health Service (NHS)'s expanding access to obesity treatments and rising public awareness of GLP-1 therapy benefits
Clinical trials show phentermine produces 5-10% body weight loss over 3-6 months
Smith TJ, Hegeds L
